1-2 of 2
Gandhi Laurent Damaj
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

Vincent Camus, Roch Houot, Gabriel Brisou, Benoit Tessoulin, Sébastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Franck Morschhauser, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérome Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5371–5381.
https://doi.org/10.1182/bloodadvances.2024013726
Published: 2024
Includes: Supplemental data
Journal Articles

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Clinical Trials & Observations
Emmanuel Bachy, Kerry J. Savage, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José María Ferreri, Gandhi Laurent Damaj, Hui Liu, Wei Zhang, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4435–4447.
https://doi.org/10.1182/bloodadvances.2022009575
Published: 2023
Includes: Supplemental data